Euroespes S.A. - Asset Resilience Ratio

Latest as of December 2022: 8.53%

Euroespes S.A. (EEP) has an Asset Resilience Ratio of 8.53% as of December 2022. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See EEP working capital efficiency to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

€973.75K

≈ $1.14 Million USD Cash + Short-term Investments

Total Assets

€11.42 Million

≈ $13.35 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2010–2024)

This chart shows how Euroespes S.A.'s Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see EEP current and non-current assets.

Liquid Assets Composition Over Time

This chart breaks down Euroespes S.A.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Euroespes S.A. (EEP) investment intensity to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€971.10K	8.5%
Short-term Investments	€2.65K	0.02%
Total Liquid Assets	€973.75K	8.53%

Asset Resilience Insights

Limited Liquidity: Euroespes S.A. maintains only 8.53% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Euroespes S.A. Industry Peers by Asset Resilience Ratio

Compare Euroespes S.A.'s asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Revvity Inc. NYSE:RVTY	Diagnostics & Research	0.00%
Hangzhou Tigermed Consulting SHE:300347	Diagnostics & Research	0.11%
Cowealth Medical China Co.Ltd. SHG:603122	Diagnostics & Research	2.25%
RHYTHM Biosciences Ltd AU:RHY	Diagnostics & Research	2.74%
Avricore Health Inc V:AVCR	Diagnostics & Research	1.71%
Imagion Biosystems Ltd AU:IBX	Diagnostics & Research	150.16%
Sonic Healthcare Ltd AU:SHL	Diagnostics & Research	0.13%
Integral Diagnostics Ltd AU:IDX	Diagnostics & Research	0.03%

Annual Asset Resilience Ratio for Euroespes S.A. (2010–2024)

The table below shows the annual Asset Resilience Ratio data for Euroespes S.A..

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	0.01%	€370.00 ≈ $432.57	€6.94 Million ≈ $8.12 Million	-0.03pp
2023-12-31	0.03%	€2.47K ≈ $2.89K	€7.93 Million ≈ $9.27 Million	-8.50pp
2022-12-31	8.53%	€973.75K ≈ $1.14 Million	€11.42 Million ≈ $13.35 Million	-7.68pp
2021-12-31	16.21%	€1.99 Million ≈ $2.32 Million	€12.25 Million ≈ $14.32 Million	-2.95pp
2020-12-31	19.16%	€2.24 Million ≈ $2.62 Million	€11.70 Million ≈ $13.68 Million	+18.98pp
2019-12-31	0.18%	€20.46K ≈ $23.93K	€11.37 Million ≈ $13.30 Million	+0.05pp
2018-12-31	0.13%	€16.85K ≈ $19.70K	€12.76 Million ≈ $14.92 Million	-0.05pp
2017-12-31	0.18%	€16.76K ≈ $19.59K	€9.35 Million ≈ $10.93 Million	+0.17pp
2016-12-31	0.00%	€436.97 ≈ $510.86	€8.90 Million ≈ $10.40 Million	-0.06pp
2015-12-31	0.06%	€4.28K ≈ $5.00K	€6.73 Million ≈ $7.87 Million	-0.04pp
2014-12-31	0.10%	€6.38K ≈ $7.46K	€6.33 Million ≈ $7.41 Million	-1.79pp
2010-12-31	1.89%	€96.76K ≈ $113.12K	€5.11 Million ≈ $5.98 Million	--

pp = percentage points

About Euroespes S.A.

MC:EEP Spain Diagnostics & Research

Market Cap

$4.61 Million

€3.95 Million EUR

Market Cap Rank

#29118 Global

#216 in Spain

Share Price

€0.34

Change (1 day)

+0.00%

52-Week Range

€0.34 - €0.34

All Time High

€1.26